Stacie Lindsey, CEO at Cholangiocarcinoma Foundation, shared a post on LinkedIn:
“As we move into the 20th year since the inception of the Cholangiocarcinoma Foundation, I am pleased to share 2026 CCF research awards:
The 2026 CCF Career Development Award: Dr. Rachel Guest, The University of Edinburgh, for IDH1/2 mutations in liver cell plasticity and cholangiocarcinoma – supported by Paul Sidenblad in memory of Kathleen Sidenblad.
The CCF 2026 Innovation Grant: Dr. Shishir Maithel, Northwestern Memorial Hospital, for Phase II, Open-label, Non-randomized, Multi-institutional Study of Optimal Preoperative Therapy for Intrahepatic Cholangiocarcinoma – funded by the Mather Family Foundation.
We are grateful to CCF donors for their continued investment in innovation, which helps improve treatments and brings us closer to a cure.”
More posts featuring Stacie Lindsey.
